Abstract:Xiao Hu, 1 Feifei Yang, 2 Yonghong Liao, 2 Lin Li, 1 Guoguang Zhao, 3 Lan Zhang 1 1 Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, People's Republic of China; 2 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, People's Republic of China; 3 Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing 100053, People's Republic of China Correspondence: Guoguang Zhao; Lan Zhang Email ggzhao@vip.sina.com; lanizhg@126.com Background and Aim: Polymeric nanoparticles (NPs) have received much attention as promising carrier systems in lung cancer and brain metastases. Methods: Here, for the first time, we investigated the feasibility of using inhaled cholesterol-PEG co-modified poly (n-butyl) cyanoacrylate NPs (CLS-PEG NPs) of docetaxel (DTX) for sustained pulmonary drug delivery in cancer metastasis. Results: Spray-dried or freeze-dried NPs yielded sustained drug release in vitro. In vitro inhalation evaluation data indicated that the inhalation formulation had better inhalability. Compared with intravenous (IV) administration, pharmacokinetic data suggested that the inhalation formulation prolonged plasma concentration of DTX for greater than 24 h and is more quickly and completely absorbed into the rat lung after intratracheal (IT) administration. Furthermore, freeze-dried powders were found to increase the t 1/2 and area under curve (AUC) by 2.3 and 6.5 fold compared to the free drug after IT administration, and spray-dried powders were found to increase the t 1/2 and AUC by 3.4 and 8.8 fold, respectively. After pulmonary administration of the inhalation formulation, DTX appeared to prolong the pulmonary absorption time. In addition, the inhalation formulation was distributed to the brain in a sustained release manner. Conclusion: These experimental results demonstrated that freeze- and spray-dried powders have the potential for pulmonary sustained release, and they also have the potential to be used as a novel treatment for the delivery of drugs that pass through the air–blood barrier and enter the brain and are efficient carriers for the treatment of brain metastasis. Keywords: pulmonary delivery, docetaxel, lung cancer, spray-drying, dry powder

Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.

Interactions of Self-Assembled Bletilla S triata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles.

Inhibition of Metastatic Bone Cancer with a Cascade Targeting of Docetaxel

Tumor Targeting with Docosahexaenoic Acid-Conjugated Docetaxel for Inhibiting Lung Cancer Metastasis to Bone

Medium-chain Triglyceride-Stabilized Docetaxel-Loaded HSA Nanoparticles Effectively Inhibited Metastatic Non-Small Cell Lung Cancer

Osteoclasts and Tumor Cells Dual Targeting Nanoparticle to Treat Bone Metastases of Lung Cancer

Active Targeting Docetaxel-Pla Nanoparticles Eradicate Circulating Lung Cancer Stem-Like Cells and Inhibit Liver Metastasis.

Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.

Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells

Docetaxel-Loaded-Lipid-Based-Nanosuspensions (Dtx-Lns): Preparation, Pharmacokinetics, Tissue Distribution and Antitumor Activity

Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.

Preparation, Characterization and Anti-Glioma Effects of Docetaxel-Incorporated Albumin-Lipid Nanoparticles

Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products

Bone-targeted PAMAM micelle to treat bone metastases of lung cancer

Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation

Enhanced Tolerance and Antitumor Efficacy by Docetaxel-Loaded Albumin Nanoparticles

Enhanced Antitumor Efficacy, Biodistribution and Penetration of Docetaxel-Loaded Biodegradable Nanoparticles.

Docetaxel-loaded PAMAM-based Poly (Γ-Benzyl-l-glutamate)-b-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles in Human Breast Cancer and Human Cervical Cancer Therapy.

Docetaxel‐Loaded Nanoparticles of Dendritic Amphiphilic Block Copolymer H40‐PLA‐b‐TPGS for Cancer Treatment

Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo

Tumour Microenvironment-Responsive Lipoic Acid Nanoparticles for Targeted Delivery of Docetaxel to Lung Cancer